Isoeugenol (2-methoxy-4-(prop-1-en-1-yl)phenol), a component of from clove (Eugenia caryophylata) oil, is a starting material for both the biotechnological and synthetic production of vanillin and vanillic acid. In this article, the isoeugenol showed excellent inhibitory effects against some metabolic enzymes such as acetylcholinesterase (AChE) enzymes, α-glycosidase, and α-amylase. Isoeugenol has the IC 50 values of 411.5 for α-amylase, 19.25 nM for αglycosidase and 77.00 nM for AChE. K i values of isoeugenol were found as 21 ± 9 nM and 16 ± 3 nM against α-glycosidase and AChE, respectively. On the other hand, tacrine as standard AChE inhibitor exhibited IC 50 value of 20.38 nM. α-Glycosidase inhibitors, commonly referred to as starch blockers, are antidiabetic drugs that help reduce edible blood glucose levels. AChE inhibitors are used for the treatment of some neurologic degenerational diseases, which involve Alzheimer's disease. Also, there is a growing interest and the need to search for newer effective and safe AChE, α-amylase, and α-glycosidase inhibitors for the treatment of some metabolic disorder.
Introduction
Clove (Eugenia caryophylata) is widely used in traditional medicine for treatment of many diseases such as digestive systems, toothaches, bacterial, and fungal infections. [1] Clove (Eugenia caryophylata) oil is very rich in terms of natural phenolic compounds including eugenol, eugenyl acetate, and isoeugenol. [2, 3] Indeed, isoeugenol (2-methoxy-4-propenyl-phenol) is present in a variety of spices. Also, it exhibits a large spectrum of biological activity. Isoeugenol is used as a sweetener, natural antioxidant, and storage agent in food and pharmaceutical processes. [4] Isoeugenol had various bioactivities including the antibacterial activity against some common food-borne pathogens. [5] It is well known that phenols including isoeugenol as biological active compounds [6] and important compounds food and pharmaceutical chemistry. In our daily life, phenolic compounds and derivatives have a great importance. [7] They are particularly characterized for their antioxidant effectiveness. [8, 9] For example, α-tocopherol is used as the most efficient phenolic compound. [10, 11] Functionalization of aromatic rings of phenols has been of great importance in areas such as food, cosmetics, pharmaceuticals, and paint industries. Eugenol and isoeugenol were used as sweeteners, and additives in food products. [12, 13] However, differences in biological activities between both phenolic compounds have been rarely studied.
Acetylcholinesterase (AChE; E.C.3.1.1.7) hydrolyzes acetylcholine (ACh), a neurotransmitter in cholinergic synapses. AChE has properties that are not found in other enzymes in terms of active site and catalytic mechanism. [14] Active site of AChE is at the bottom of the narrow gutter structure and consists of two subunits. The first is the negatively charged or the anionic region; the second is the esterified region containing the catalytic moiety, or the catalytic triad (Ser203, Glu334, and His447). [15] The catalytic triad is temporarily attached to the acyl region of the substrate. The hydrophobic subunit and the acyl pocket contain the alcohol group in the case of tetrahedral transition. [16] Oxygenation hole stabilizes the transition state by providing negative carbonyl oxygen. In addition to the catalytic triad, all known AChE contains a second substrate-binding domain termed the peripheral anionic domain. Cholinesterase inhibition is also used in the production of chemical gas to produce lethal acetylcholinergic stimulation as used for therapeutic purposes to increase acetylcholine (ACh) in the synaptic range in diseases such as Alzheimer's disease (AD), which is one of the most common neurodegenerative disorders. Myasthenia gravis, which persists with ACh insufficiency. [17] The human brain contains mainly two types of cholinesterase including AChE and butyrylcholinesterase (BChE; E.C.3.1.1.8). The human brain contains indicated both cholinesterases. [18] The reaction catalyzed by AChE occurs enzymatically in two steps. Firstly, the enzyme acts as a strong nucleophile; then, it acts as a perfect disintegrating group through a nucleophilic hydroxyl group of a specific serine residue. [19] The main function of AChE is the termination of cholinergic neurotransmission. BChE's physiological function has not been known; however, it hydrolyzes ACh and other choline esters. AD arises as a result of the reduction of neurotransmitters in the brain. The decrease in the brain in ACh levels is the biggest change in the biochemical sense of AD. There is no definitive treatment of AD. The treatments currently used are intended to eliminate the symptoms of the disease. [20] Diabetes is one of the most serious health problems of the century. It continues to increase rapidly all over the world and affects more and more people every day. [21, 22] Growing pandemic increases the consumption of health resources in every country around the world and causes many people in working age to become inoperable and die prematurely. [23] Diabetes authorities and nongovernmental organizations report that if something is not done, diabetes will affect more people in the world. Diabetes is classified into four groups including gestational diabetes, other specific types, Type 1 diabetes (T1DM), and Type 2 diabetes mellitus (T2DM). The first one is more acute in children and adolescents with insulin deficiency due to pancreas β cell destruction. T2DM is a prominent insulin resistance and insulin secretion disorders. Approximately 90-95% of all people with diabetes are on T2DM. While gestational diabetes describes diabetes that occurs during pregnancy, other specific types define the high blood glucose level that occurs for many reasons affecting the pancreas. [24, 25] In the literature, there are negligible studies on the effects of isoeugenol on these metabolic enzymes. Therefore, the study has novelty and completely original. The aim of this paper was to determine the inhibition effects of isoeugenol against some metabolic enzyme including AChE, α-glycosidase, and αamylase. Another goal of this study is to compare the inhibition effects of isoeugenol with standard enzymes inhibitors including acarbose (for α-amylase and α-glycosidase enzymes) and tacrine (for AChE).
Materials and methods
Chemicals p-Nitrophenyl α-D-glycopyranoside (p-NPG), achethylycholinesteras from electric eel (Electrophorus electricus), α-amylase from porcine pancreas, α-glycosidase from Saccharomyces cerevisiae, isoeugenol (CAS Number: 97-54-1) and starch were bought from Sigma-Aldrich (G5003; St.Louis, MO).
α-glycosidase activity
For this enzyme, p-NPG was used as the substrate. The samples were prepared by dissolving ethanol (1 mg/mL). Firstly, 100 μL of NaH 2 PO 4 with pH 7.4 and 10 μL of enzyme solution were mixed (Table 1) . And then, 50-100 μL of the samples were added into the current solution and these were mixed. [26] After, it was preincubated at 35°C for 10 min by adding the p-NPG to initiate the reaction. In addition, 50 μL of p-NPG at pH 7.4 of NaH 2 PO 4 (5 mM) after preincubation was added and the incubation was again carried out at 35°C. IC 50 and K i values were evaluated with the obtained data. Acarbose was used as a positive control. Absorbance values were spectrophotometrically measured at 405 nm. [27] α-amylase activity α-Amylase activity and inhibition study of this enzyme were spectrophotometrically measured at 580 nm according to the procedure of Xiao et al. [28] Starch was used as substrate conforming to previous studies. [29] In this work, for preparing starch solution, 0.5 g of starch was dissolved in 20 mL NaOH solution (0.4 M) and heated for 30 min at 80°C, then cooled in iced water, with HCl (2.0 M). The solution pH was adjusted to 6.9 and using water was added to complete 25 mL. Sample solutions were prepared by dissolving 5 mg in 0.5 mL (EtOH: water). Multiple solutions in phosphate buffer were prepared in case of getting entire enzyme inhibition. 35 µL of substrate, 35 µL of phosphate buffer (pH 6.9), and 5 µL of sample solutions were mixed and preincubated at 35°C for 30 min. Then, 20 µL of a 50 µg/mL enzyme was added and re-incubated for 30 min ( Table 2 ). The reaction was finished by addition of 50 µL of HCl (0.1 M). The absorbance was spectrophotometrically measured at 580 nm.
Acetylcholinesterase inhibitory study
The inhibitory effect of isoeugenol on AChE activity was performed according to Ellman's procedure [30] as described in the previous study. [31] Acetylthiocholine iodide (AChI) was used as a substrate for the cholinergic reaction. In brief, an aliquot (100 µL) of Tris/HCl buffer (pH 8.0, 1.0 M) and different concentration of sample solutions (10-30 µg/mL) were added to 50 µL of AChE solution (5.32 × 10 −3 EU). The mixture was incubated at 20°C for 10 min. An aliquot (50 µL, 0.5 mM) of DTNB (5,5ʹ-dithio-bis(2-nitro-benzoic)acid) and AChI were added to incubated mixture and enzymatic reactions were initiated (Table 3) . AChE activities were spectrophotometrically determined at 412 nm. [31, 32] 
Results and discussion
Isoeugenol as a natural phenol derivative was used medical and cosmetics industries for its antioxidant, anticancer, antigenotoxic and anti-inflammatory properties. It is widely used as preservatives and flavors, sweeteners, antioxidants, and fragrances. [1, [33] [34] [35] Essential oils, which can be named as essence oil, essential oil or aromatic oil, take place an important role in plant phytochemistry. [34] Mostly, they have a strong odor, colorless or light yellow color, liquid form or freezing properties at room temperature. Essential oils are mostly used as antibacterial compounds in plant extracts. Isoeugenol is component an essential oil naturally found in plants. [35, 36] Evaluation of the effects of the isoeugenol on AChE, α-amylase, and α-glycosidase was an important aim of this article and inhibition findings are represented in Table 4 . The chemical structure of isoeugenol is shown in Figure 1 . Half maximal inhibition concentration (IC 50 ) is a measure of the potency of a substance in inhibiting a specific biological or biochemical function. [39, 40] Also, the IC 50 value of isoeugenol against some metabolic enzymes was investigated.
AD is the most common cause of dementia in aged people and is one of the ten main causes of death in the world loss is clinically defined by irreversible cognitive and rising language impairment and extreme behavioral abnormalities and disorders. AD occurs as a result of malfunctions of different biochemical pathways and is usually seen in older people. [41, 42] T2DM is an intense endocrinal functionless that causes postprandial hyperglycemia, leading to challenging long-term disorders such as cardiovascular disease, diabetic neuropathy, diabetic retinopathy, and diabetic nephropathy. [42] α-Amylase and α-glycosidase for hydrolyzing of polysaccharides are responsible for the final stage of the digestion of glycogen and starch. Inhibitors of both digestive enzymes are drug candidates and potential functional food factors to postpone postprandial absorption of glucose. [43] α-Amylase, α-glycosidase, and AChE were investigated in the enzyme inhibition stage. The inhibitory effects of the isoeugenol compound against AChE, α-amylase, and α-glycosidase are Table 3 . Cuvette content of the study with acetylcholinesterase method.
Materials used
Control tube (µL) Sample tube (µL) Tris- HCl  100  100  Pure water  790  780  Sample  -10  DTNB  50  50  Enzyme solution  10 10 Incubated at 30ºC for 5 minutes Acetylcholine thioiodide 50 50 It was used as positive control for α-amylase and α-glycosidase enzymes and determined as µM levels, which taken from literatures. [37, 38] c Tacrine was used as a positive control for acetylcholinesterase (AChE) enzyme. summarized in Table 4 . The following results can be clearly observed from the inhibition data. AD causes a decrease in neurotransmitters in the brain. [44] The neurotransmitter with the highest decrease in this disease is ACh. Also, there is a growing interest and the need to search for newer effective and safe AChE, α-amylase and α-glycosidase inhibitors for the treatment of some metabolic disorder. In this research, IC 50 and K i factors of the isoeugenol compound were studied and the results are shown in Table 4 and Figure 2 . In this paper, we investigated the AChE inhibitory potential of the isoeugenol compound. Starch is a polysaccharide. Consequently, it is not possible to adjust the concentration as the substrate since it is not monomeric. Therefore, Ki values could not be calculated for α-amylase enzyme. For this enzyme, the isoeugenol compound had an IC 50 77.00 nM and K i value of 16 ± 3 nM (Table 4 ). IC 50 values of isoeugenol and standard (tacrine) exhibited the following order: Tacrine (20.38 nM) < isoeugenol (77.00 µM). It was reported that plants secondary metabolites with different structural features including sterols, flavonoids, terpenoids, and phenolic compounds have been recognized as AChE inhibitors and promising lead compounds for AD. [45] Enzymes as macromolecule had a large spectrum of biological catalysis and chemical reactions. [46] [47] [48] [49] [50] [51] [52] By providing ACh hydrolysis, a neurotransmitter is carried out after the delivery of this substance is achieved. ACh is an ester of great biological importance. While AChE breaks down the ACh neurotransmitter as acetate and choline, other neurotransmitters do not break down serotonin, dopamine, and norepinephrine. [53] Neurotransmitters like norepinephrine, dopamine, and serotonin are absorbed by the synaptic space and take an essential role in central nerve conduction. AChE is mainly found in brain, muscle, nerve cells and erythrocytes. Pseudocholinesterase has the same mechanism, but is present in the plasma and circulates the destruction of ACh. [54] Reactive oxygen species and oxidants produced from activated neutrophils and macrophages get a crucial role in neurodegenerative diseases like AD and painful pathogenic diseases. [10] Reduction of AChE for treatment or prevention of the disease should be reduced and this is possible by the inhibition of AChE, which breaks down acetylcholine. The AChE active site consists of five major binding sites. Firstly, the oxyanion pit is in equilibrium with tetrahedral transition. [55] The second active region of AChE is the esteratic region. This region consists of serine residues and attacks the esteratic carbonyl group (C = O). The third active site is the binding region of anionic substrates, whereas in this region the negative charge is small, while the aromatic residues are numerous. As known, ACh has a quarternary ammonium tip. [56] The Z electrons of the aromatic groups in this active site are bound by the preferential interaction of ACh to the quaternary nitrogen atom. The fourth active region is the selective aromatic binding region. In this region, the esteratic and anionic regions are close. [57] Therefore, this active site is important for aryl substrates and active site ligands. Finally, the fifth active site is the peripheral anion-binding site. The peripheral anionic binding site may be attached to the hydrophobic moiety of the group, which is separated from the active moiety. [58] Drugs used and designed for AD are used to adjust the level of acetylcholine and are designed accordingly. Acetylcholine is involved in signal transduction in synapses. After signal transduction to the synapses, it is hydrolyzed with AChE to break down into choline and acetate compound. Phenolic compounds remove free radicals and prevent diseases caused by them. One of these is AD. In this study, the AChE inhibition effects of isoeugenol were investigated. The inhibition effect on the AChE enzyme was investigated and the inhibition type, K i and IC 50 value were calculated. Tacrine molecule was used as standard. When all these results are evaluated, it can be a guide in pharmacological studies, the results are thought to be a triggering factor in the investigation of AD and treatment of this disease. [59, 60] α-Glycosidase enzyme (E.C.3.2.1.20) release from intestine cells and hydrolyzes oligosaccharides and polysaccharide to monosaccharide units, such as glucose and fructose in the small intestine. [34, 41] In human, α-glycosidase inhibitors (α-GIs) had a great importance for controlling of T2DM and hyperglycemia. [61] Recently, two main chemical classes of N-comprising α-GIs contain sugar-based inhibitors. [37] α-GIs can reduce the uptake of dietary carbohydrates and repress postprandial hyperglycemia and T2DM. Thus, these α-GIs are endowed with sugar molecule such as compete and moieties with the oligosaccharides for binding to the active site of the enzyme, hence effectively reducing the postprandial glucose amounts in T2DM. [38, 62, 63] On the other hand, for this study, the α-glycosidase assay which performed according to the method of Tao et al. [64] , is presented on cells lining the intestine, hydrolyzing monosaccharides to be absorbed through the intestine, isoeugenol exhibited IC 50 value of 19.25 nM and Ki value of 21 ± 9 nM ( Table 2 ). The results obtained from αglycosidase assay showed that isoeugenol had effective α-glycosidase inhibition profile than that of acarbose (IC 50 : 22.8 μM) as α-GIs. [65, 66] Also, highly effective IC 50 value was obtained against α-amylase with IC 50 value of 411.5 nM. The inhibition of digestive enzymes had great importance due to treating and preventing T2DM, postprandial glucose amounts and hyperglycemia. [67] 
Conclusion
Isoeugenol was found to be powerful anticholinergic and antidiabetic effects when compared to standard compounds. Acetylcholine is one of the key neurotransmitters for peripheral nervous system. The inhibition of AChE has been proposed as a drug for neurotoxicity. On the other hand, α-amylase and α-glycosidase release from intestine cells and hydrolyzes oligosaccharides and polysaccharide to monosaccharide units. Therefore, isoeugenol had effective inhibition profiles against both digestion enzymes. Hence, isoeugenol can be used for the treatment of mild-tomoderate AD, various other memory diseases and T2DM.
